Seek Returns

RGEN vs. TMO: Repligen vs. Thermo Fisher Scientific Stock Comparison

How do Repligen (RGEN) and Thermo Fisher Scientific (TMO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Repligen (RGEN) and Thermo Fisher Scientific (TMO) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
Profile ItemRGENTMO
NameRepligen CorporationThermo Fisher Scientific Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization11.09 billion USD257.42 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateApril 29, 1986March 17, 1980
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

RGEN
TMO
GSPC
Loading price history…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Repligen (RGEN) and Thermo Fisher Scientific (TMO). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Repligen (RGEN) and Thermo Fisher Scientific (TMO). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Total Return (1Y)23.28%24.62%
Total Return (3Y, Annualized)6.20%17.34%
Total Return (5Y, Annualized)-8.41%3.11%

Risk Profile

Drawdown History

RGEN
TMO
GSPC
Loading price history…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Repligen (RGEN) and Thermo Fisher Scientific (TMO). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Volatility (1Y, Annualized)46.73%29.96%
Beta (5Y)1.110.83
Max Drawdown (5Y)-64.67%-40.95%
Avg. Volume (3M)1.18M2.10M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
RGEN and TMO are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Sharpe Ratio (1Y)0.410.68
Sortino Ratio (1Y)0.601.02

Profitability

ROE (TTM)

Repligen (RGEN) reports a negative ROE of -0.57%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Thermo Fisher Scientific (TMO) reports 13.38%, ranking against industry peers normally.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-0.57%

Max
109.18%
Q3
6.23%
RGEN
-0.57%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.38%

Max
109.18%
TMO
13.38%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Repligen (RGEN) reports a negative net margin of -1.47%, usually indicating a net loss over the period. Meanwhile Thermo Fisher Scientific (TMO) reports 14.94%, ranking against industry peers normally.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-1.47%

Max
18.05%
Q3
4.78%
Median
0.00%
RGEN
-1.47%
Q1
-4.14%
Min
-17.05%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.94%

Max
18.05%
TMO
14.94%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Thermo Fisher Scientific (TMO) at 20.19% operates in the top operating margin quartile, ahead of Repligen (RGEN) at 6.19%, which runs around its industry’s norm.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.19%

Max
83.12%
Q3
14.77%
RGEN
6.19%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.19%

Max
83.12%
TMO
20.19%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
ROE (TTM)-0.57%13.38%
ROA (TTM)1.40%5.19%
Net Margin (TTM)-1.47%14.94%
Operating Margin (TTM)6.19%20.19%
Gross Margin (TTM)53.77%41.26%

Growth

Revenue Growth

Both Repligen (RGEN) at 16.36% and Thermo Fisher Scientific (TMO) at 3.91% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Thermo Fisher Scientific (TMO) reports EPS growth of 7.32%, ranked against its industry; Repligen (RGEN) has no EPS growth figure this period.

Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Revenue Growth (YoY)16.36%3.91%
Revenue Growth (3Y CAGR)-2.70%-0.27%
EPS Growth (YoY)--7.32%
EPS Growth (3Y CAGR)-35.73%0.21%

Financial Strength

Current Ratio (MRQ)

Repligen (RGEN) at 9.88 keeps current ratio within its industry’s typical mid-range, while Thermo Fisher Scientific (TMO) at 1.81 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for TMO.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.88

Max
25.13
Q3
12.13
RGEN
9.88
Median
5.52
Q1
2.47
Min
0.10

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.81

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
TMO
1.81
Min
0.10
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Repligen (RGEN) at 0.33 carries an industry-typical debt-to-equity mix, while Thermo Fisher Scientific (TMO) at 0.75 uses more debt funding than most peers.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.33

Max
1.42
Q3
0.65
RGEN
0.33
Median
0.15
Q1
0.02
Min
0.00

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.75

Max
1.42
TMO
0.75
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Current Ratio (MRQ)9.881.81
Debt / Equity (MRQ)0.330.75
Net Debt / EBITDA-1.192.91

Dividends

Dividend Yield (TTM)

Repligen (RGEN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a yield of 0.27%, ranking against industry peers normally.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

RGEN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27%

TMO
0.27%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Repligen (RGEN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a payout of 9.70%, ranking against industry peers normally.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

RGEN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.70%

TMO
9.70%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
Dividend Yield (TTM)0.00%0.27%
Dividend Payout Ratio (TTM)0.00%9.70%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Thermo Fisher Scientific (TMO) trades at 36.64 times trailing earnings, ranked against its peers, while Repligen (RGEN) has no P/E ratio this period.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
RGEN
--

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.64

Max
85.34
Q3
43.46
TMO
36.64
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): RGEN does not report P/E ratio, so it has no value marker; TMO is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

On P/S ratio, both Repligen (RGEN) at 13.77 and Thermo Fisher Scientific (TMO) at 5.44 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.77

Max
58.18
Q3
25.77
RGEN
13.77
Median
7.30
Q1
3.01
Min
0.01

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.44

Max
58.18
Q3
25.77
Median
7.30
TMO
5.44
Q1
3.01
Min
0.01
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Repligen (RGEN) at 4.70 and Thermo Fisher Scientific (TMO) at 4.70 are valued close to their industries’ norm against book — neither stands out from peers.

RGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70

Max
13.53
Q3
6.54
RGEN
4.70
Median
3.25
Q1
1.69
Min
-5.59

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70

Max
13.53
Q3
6.54
TMO
4.70
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Repligen (RGEN) vs. Thermo Fisher Scientific (TMO): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Repligen (RGEN) and Thermo Fisher Scientific (TMO)
MetricRGENTMO
P/E Ratio (TTM)--36.64
P/S Ratio (TTM)13.775.44
P/B Ratio (MRQ)4.704.70
Free Cash Flow Yield (TTM)1.01%2.50%